Safdar S. Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Safdar S. Khan has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Henrietta Bada
Division of Neonatology, Department of Pediatrics, University of Kentucky, Lexington, Kentucky
2 shared publicationsMina Hanna
Division of Neonatology, Department of Pediatrics, College of Medicine, University of Kentucky, Lexington, Kentucky
2 shared publicationsDouglas Schneider
Division of Cardiology, Department of Pediatrics, University of Kentucky, Lexington, Kentucky
1 shared publicationH S Bada
Division of Neonatology, Department of Pediatrics, College of Medicine, University of Kentucky, Lexington, KY, USA
1 shared publicationHenrietta S. Bada
Division of Neonatology, Department of Pediatrics, College of Medicine, University of Kentucky, Lexington, Kentucky
1 shared publicationIrene Hong-McAtee
Vanderbilt University, Nashville, TN, USA
1 shared publication
Latest Publications
- 9 November 2021
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 39 (10) , 1027-1032
The Trend of Urinary N Terminal Probrain Natriuretic Peptide in Extremely Low Birth Weight Infants during the Neonatal Period
Objective N-terminal probrain natriuretic peptide (NT-proBNP) is a biomarker of interest in many cardiopulmonary diseases in extremely low birth weight (ELBW) Infants. However, there is a gap in knowledge about the trend of ELBW infant's urinary NT-proBNP during the neonatal period. Aim To determine the trend of urinary NT-proBNP during the first 4 weeks of life of an ELBW infant. Study Design We analyzed prospectively enrolled 87 ELBW infants. Urinary NT-proBNP to creatinine ratios were measured on days 1 to 7, 14, and 28 of life. We plotted each study point's means to determine the trend of urinary NT-proBNP over the entire neonatal period. Data were analyzed using the Friedman analysis of variance for comparative analysis of study points. Results Urinary NT-proBNP/creatinine ratios were significantly elevated on days 1 to 7 (mean 2,452, ± 1,518) than day 14 (mean 747, ± 176), and day 28 (mean 149, ± 54), p = 0.001. Overall, urinary NT-proBNP levels were highest during days 1 to 3 (mean 3,232, ± 1,255) and lowest on day 28 (mean 149, ± 54). Conclusion Urinary NT-proBNP levels are higher during the first week in ELBW infants with a downward trend during the neonatal period, the lowest values at 4 weeks postnatal age. More studies are required to determine the clinical utility of this trend during and beyond the neonatal period. Key Points
- 9 November 2021
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 39 (10) , 1027-1032
The Trend of Urinary N Terminal Probrain Natriuretic Peptide in Extremely Low Birth Weight Infants during the Neonatal Period
Objective N-terminal probrain natriuretic peptide (NT-proBNP) is a biomarker of interest in many cardiopulmonary diseases in extremely low birth weight (ELBW) Infants. However, there is a gap in knowledge about the trend of ELBW infant's urinary NT-proBNP during the neonatal period. Aim To determine the trend of urinary NT-proBNP during the first 4 weeks of life of an ELBW infant. Study Design We analyzed prospectively enrolled 87 ELBW infants. Urinary NT-proBNP to creatinine ratios were measured on days 1 to 7, 14, and 28 of life. We plotted each study point's means to determine the trend of urinary NT-proBNP over the entire neonatal period. Data were analyzed using the Friedman analysis of variance for comparative analysis of study points. Results Urinary NT-proBNP/creatinine ratios were significantly elevated on days 1 to 7 (mean 2,452, ± 1,518) than day 14 (mean 747, ± 176), and day 28 (mean 149, ± 54), p = 0.001. Overall, urinary NT-proBNP levels were highest during days 1 to 3 (mean 3,232, ± 1,255) and lowest on day 28 (mean 149, ± 54). Conclusion Urinary NT-proBNP levels are higher during the first week in ELBW infants with a downward trend during the neonatal period, the lowest values at 4 weeks postnatal age. More studies are required to determine the clinical utility of this trend during and beyond the neonatal period. Key Points
- 23 December 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 55 (2) , 376-382
Role of NT‐proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants
Objective: The objective of the study was to determine the clinical utility of brain natriuretic peptide (NT‐proBNP) for prediction of moderate to severe bronchopulmonary dysplasia (BPD). We hypothesized that elevated NT‐proBNP levels at 4 weeks of postnatal age may predict the severity of BPD in preterm infants.Study Design: The study design was a prospective observational study. The research team enrolled and followed a cohort of 70 infants with gestational age less than or equal to 30 weeks. The plasma NT‐proBNP levels were measured at the postnatal day 28th. We further followed and categorized infants into two groups. Infants with no or mild BPD (Group 1) and infants with moderate or severe BPD (Group 2). We compared plasma NT‐proBNP levels at 28th day of postnatal life between Groups 1 and 2. The difference in NT‐proBNP levels on day 28th between groups was used to predict the severity of BPD.Results: Plasma NT‐proBNP was significantly elevated in Group 2 compared with Group 1, median (IQR) of 845 pg/mL (553, 1632) compared with 726 pg/mL (391, 923), P = 0.02. NT‐proBNP had a fair predictive accuracy (C statistics of 0.68) to determine moderate to severe BPD.Conclusion: NT‐proBNP may be a useful biomarker in conjunction with clinical factors as a predictor of severe BPD. For future directions, the trend of NT‐proBNP in infants with BPD may have clinical significance in monitoring of the disease.
- 23 December 2019
- Published by Wiley in Pediatric Pulmonology
- Vol. 55 (2) , 376-382
Role of NT‐proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants
Objective: The objective of the study was to determine the clinical utility of brain natriuretic peptide (NT‐proBNP) for prediction of moderate to severe bronchopulmonary dysplasia (BPD). We hypothesized that elevated NT‐proBNP levels at 4 weeks of postnatal age may predict the severity of BPD in preterm infants.Study Design: The study design was a prospective observational study. The research team enrolled and followed a cohort of 70 infants with gestational age less than or equal to 30 weeks. The plasma NT‐proBNP levels were measured at the postnatal day 28th. We further followed and categorized infants into two groups. Infants with no or mild BPD (Group 1) and infants with moderate or severe BPD (Group 2). We compared plasma NT‐proBNP levels at 28th day of postnatal life between Groups 1 and 2. The difference in NT‐proBNP levels on day 28th between groups was used to predict the severity of BPD.Results: Plasma NT‐proBNP was significantly elevated in Group 2 compared with Group 1, median (IQR) of 845 pg/mL (553, 1632) compared with 726 pg/mL (391, 923), P = 0.02. NT‐proBNP had a fair predictive accuracy (C statistics of 0.68) to determine moderate to severe BPD.Conclusion: NT‐proBNP may be a useful biomarker in conjunction with clinical factors as a predictor of severe BPD. For future directions, the trend of NT‐proBNP in infants with BPD may have clinical significance in monitoring of the disease.
- Open Access
- 30 July 2018
- Published by Springer Nature in Journal of Perinatology
- Vol. 38 (10) , 1353-1358
Thyroid gland volumes in premature infants using serial ultrasounds
There is a gap in knowledge about the postnatal growth of thyroid gland in preterm infants. To determine postnatal growth of thyroid gland in preterm infants. Thyroid gland volume was calculated in 57 prospectively enrolled preterm infants by measuring serial longitudinal, antero-posterior, and transverse dimensions of thyroid gland with ultrasound. Data were analyzed by using the Wilcoxon and independent t test. There was a significant correlation between thyroid volume (TV) and birthweight (BW) (p = 0.01), and between TV and gestational age (p = 0.02). However, unexpectedly, 12 infants had a decrease in TV between the first and second ultrasounds. Infants with late onset bacterial sepsis had lower TVs on their second ultrasounds than infants without sepsis. Thyroid ultrasound in preterm infants provides noninvasive and quick approach to determine TV and morphology. TV in preterm infants correlates positively with BW and gestational age. However, postnatal growth of thyroid gland is variable and may seemingly be affected by postnatal factors.
- 30 July 2018
- Published by Springer Nature in Journal of Perinatology
- Vol. 38 (10) , 1353-1358
Open AccessThyroid gland volumes in premature infants using serial ultrasounds
There is a gap in knowledge about the postnatal growth of thyroid gland in preterm infants. To determine postnatal growth of thyroid gland in preterm infants. Thyroid gland volume was calculated in 57 prospectively enrolled preterm infants by measuring serial longitudinal, antero-posterior, and transverse dimensions of thyroid gland with ultrasound. Data were analyzed by using the Wilcoxon and independent t test. There was a significant correlation between thyroid volume (TV) and birthweight (BW) (p = 0.01), and between TV and gestational age (p = 0.02). However, unexpectedly, 12 infants had a decrease in TV between the first and second ultrasounds. Infants with late onset bacterial sepsis had lower TVs on their second ultrasounds than infants without sepsis. Thyroid ultrasound in preterm infants provides noninvasive and quick approach to determine TV and morphology. TV in preterm infants correlates positively with BW and gestational age. However, postnatal growth of thyroid gland is variable and may seemingly be affected by postnatal factors.
- 14 September 2017
- Published by Springer Nature in Journal of Perinatology
- Vol. 37 (12) , 1319-1324
Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus
Patent ductus arteriosus (PDA) is common in preterm infants and is associated with significant morbidities. B type natriuretic peptide (BNP) is synthesized in the ventricles secondary to volume overload and excreted as urinary N-terminal pro-brain natriuretic peptide (NT-proBNP). We report an observational prospective study of 64 preterm infants with birth weight ⩽ 1000 g. Echocardiographic parameters were obtained from clinical echocardiograms performed in the first week of life. Urinary NT-proBNP/creatinine ratios (pg mg−1) were measured on the same day of the echocardiograms. Infants with medium to large PDA (n=39) had significantly higher NT-proBNP/creatinine levels compared with infants with small PDA (n=10) (median (IQ range): 2333 (792–6166) vs 714 (271–1632) pg mg−1, P=0.01) and compared with infants with no PDA (n=15) (2333 (792–6166) vs 390 (134–1085) pg mg−1, P=0.0003). Urinary NT-proBNP/creatinine ratios were significantly lower post treatment if PDA closed (n=17), P=0.001 or if PDA became smaller after treatment (n=9), P=0.004. Urinary NT-proBNP/creatinine levels correlated with ductal diameter (P ⩽ 0.0001), but not with LA/Ao ratio (P=0.69) or blood flow velocity through the ductus (P=0.06). Our findings indicate that there is a positive correlation between ductal diameter and urinary NT-proBNP in preterm infants.
- 14 September 2017
- Published by Springer Nature in Journal of Perinatology
- Vol. 37 (12) , 1319-1324
Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus
Patent ductus arteriosus (PDA) is common in preterm infants and is associated with significant morbidities. B type natriuretic peptide (BNP) is synthesized in the ventricles secondary to volume overload and excreted as urinary N-terminal pro-brain natriuretic peptide (NT-proBNP). We report an observational prospective study of 64 preterm infants with birth weight ⩽ 1000 g. Echocardiographic parameters were obtained from clinical echocardiograms performed in the first week of life. Urinary NT-proBNP/creatinine ratios (pg mg−1) were measured on the same day of the echocardiograms. Infants with medium to large PDA (n=39) had significantly higher NT-proBNP/creatinine levels compared with infants with small PDA (n=10) (median (IQ range): 2333 (792–6166) vs 714 (271–1632) pg mg−1, P=0.01) and compared with infants with no PDA (n=15) (2333 (792–6166) vs 390 (134–1085) pg mg−1, P=0.0003). Urinary NT-proBNP/creatinine ratios were significantly lower post treatment if PDA closed (n=17), P=0.001 or if PDA became smaller after treatment (n=9), P=0.004. Urinary NT-proBNP/creatinine levels correlated with ductal diameter (P ⩽ 0.0001), but not with LA/Ao ratio (P=0.69) or blood flow velocity through the ductus (P=0.06). Our findings indicate that there is a positive correlation between ductal diameter and urinary NT-proBNP in preterm infants.